A Phase <scp>II</scp> Trial of Lutikizumab, an Anti–Interleukin‐1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With SynovitisRoy Fleischmann, Marc C. Levesque, Charles G. Peterfy et al.|Arthritis & Rheumatology|2019Cited by 209
Perivascular Lymphocyte Clusters Induced by Gastric Subserous Layer Vaccination Mediate Optimal Immunity against Helicobacter through Facilitating Immune Cell Infiltration and Local Antibody ResponseChupeng Hu, Yingying Xing, Wei Liu et al.|Journal of Immunology Research|2020Cited by 4